Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kai Blöndal"'
Autor:
Eva Nathanson, Catharina Lambregts-van Weezenbeek, Michael Rich, Rajesh Gupta, Jaime Bayona, Kai Blöndal, José A. Caminero, J. Peter Cegielski, Manfred Danilovits, Marcos A. Espinal, Vahur Hollo, Ernesto Jaramillo, Vaira Leimane, Carole D. Mitnick, Joia S. Mukherjee, Paul Nunn, Alexander Pasechnikov, Thelma E. Tupasi, Charles Wells, Mario C. Raviglione
Publikováno v:
Emerging Infectious Diseases, Vol 12, Iss 9, Pp 1389-1397 (2006)
Evidence of successful management of multidrug-resistant tuberculosis (MDRTB) is mainly generated from referral hospitals in high-income countries. We evaluate the management of MDRTB in 5 resource-limited countries: Estonia, Latvia, Peru, the Philip
Externí odkaz:
https://doaj.org/article/31f5914dcfb44911a842b9a4fcafdbba
Autor:
Ari Karason, Jeffrey C. Barrett, Daniel F. Gudbjartsson, Unnur Thorsteinsdottir, Adalbjorg Jonasdottir, Kai Blöndal, Olafur Th Magnusson, Aslaug Jonasdottir, Hafdis T. Helgadottir, Larus J. Gudmundsson, Helgi Kristjansson, Yang Luo, Kari Stefansson, Gardar Sveinbjornsson, Gisli Masson, Mar Kristjansson, Arnaldur Gylfason, Augustine Kong, Ljiljana Bulat Kardum, Sigurjon A. Gudjonsson, Ingileif Jonsdottir, Arthur Löve, Jelena Knežević, Magnus Gottfredsson, Bjarni V. Halldorsson, Thorsteinn Blondal, Zlatko Dembic, Sergey Nejentsev, Karl G. Kristinsson, Patrick Sulem
Publikováno v:
Nature genetics
Volume 48
Issue 3
Volume 48
Issue 3
To access publisher's full text version of this article click on the hyperlink at the bottom of the page Mycobacterium tuberculosis infections cause 9 million new tuberculosis cases and 1.5 million deaths annually. To identify variants conferring ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5b89bffddebb172874ac73822dc1dd5
https://repository.medri.uniri.hr/islandora/object/medri:5364
https://repository.medri.uniri.hr/islandora/object/medri:5364
Autor:
Kai, Blöndal
Publikováno v:
Bulletin of the World Health Organization. 85:387-390
The development and expansion of WHOs DOTS strategy was successful, with 83% of the worlds population living in countries or parts of countries covered by this strategy by the end of 2004. Treatment success in the 2003 DOTS cohort of 1.7 million pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc462cbe451b4e956ebfa423c578269b
https://doi.org/10.2471/blt.06.035345
https://doi.org/10.2471/blt.06.035345
Autor:
Kai Blöndal
Publikováno v:
Bulletin of the World Health Organization, Vol 85, Iss 5, Pp 387-390
The development and expansion of WHO’s DOTS strategy was successful, with 83% of the world’s population living in countries or parts of countries covered by this strategy by the end of 2004. Treatment success in the 2003 DOTS cohort of 1.7 millio
Externí odkaz:
https://doaj.org/article/e99a0157c7764765a8a36811fa1a9238
Publikováno v:
Laeknabladid. 95(7-8)
Multidrug resistant tuberculosis (MDR-TB) is a growing health problem in the world. Treatment outcomes are poorer, duration longer and costs higher. We report three cases of MDR-TB diagnosed in Iceland in a six year period, 2003-8.The first case was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a909d3b1c7d4d19e178cec3c662247ac
https://pubmed.ncbi.nlm.nih.gov/19553708
https://pubmed.ncbi.nlm.nih.gov/19553708
Publikováno v:
Bulletin of the World Health Organization. May2007, Vol. 85 Issue 5, p387-390. 4p.
Autor:
WHO
'The emergence of extensively drug-resistant strains of tuberculosis, especially in countries with a high prevalence of human immunodeficiency virus, is a serious threat to global public health and jeopardizes efforts to effectively control the disea
Autor:
Lee B. Reichman, Earl S. Hershfield
Thoroughly examining tuberculosis from historical, theoretical, and clinical perspectives, this Third Edition merges state-of-the-art research developments with principles of programmatic TB management. Each of the 50 chapters analyze current studies